- Filter by
- Categories
- Tags
- Show all
- Article
- Confusion
- Contract
- Copyright
- Corporate
- Domain Names
- Employment
- Expungement
- Expungement
- Grey Marketing
- Industrial Designs
- Licensing
- Obviousness
- Opposition
- Passing Off
- Patent
- Patent Infringement
- Patent Strategy
- PM(NOC)
- Procedure
- Prosecution
- recognition
- Services
- Summary
- Trade Secrets
- Trade-mark
- Use
- Validity
- 2019
- 35 US Code §101
- 3D printing
- 6.08
- Abandonment
- abstract
- abstract theorems
- accounting of profits
- acquired distinctiveness
- actions
- actual notice
- agreement
- agreements
- airport security
- Alice/Mayo Test
- Ambiguity
- Amending
- amendment
- Amendments
- annual maintenance fee
- Anticipation
- Appeal
- application
- application chain
- application fee
- arbitrary
- arbitration
- Assignment
- Australia
- Bad Faith
- bill
- Bill C-31
- Bill C-43
- Bill C-8
- Bill C-86
- biologics
- biosimilar
- Biotech Patents
- border measures
- Brand
- branding
- broadcasting
- budget
- burden of proof
- business
- CAFC
- call processing
- Canada
- Canada Gazette
- causal link
- cdrp
- CEEO
- Certificate of Supplementary Protection
- champerty
- Chemical Patent
- chemistry
- ciba
- CIPO
- CIPO errors
- CIRA
- Claim Construction
- Class Actions
- clerical error
- college of agents
- combination
- combination drugs
- commissioner
- Common General Knowledge
- Complete Code
- confidential
- Confidential Information
- confidentiality
- confidentiality order
- Conflict of Interest
- confusing
- confusingly similar
- confusion
- constitution
- constitutional
- constitutionality
- consumer goods
- contract
- contributory infringement
- Copyright
- Copyright Infringement
- copyright test
- corrections
- Costs
- counterfeit
- CSP
- cybersecurity
- Damages
- Data
- Data Protection
- deadline
- deadlines
- defamation
- defences
- delay to market entry
- delayed market entry
- descriptive
- Design Patents
- deviation
- digital infringement
- disclosure
- distinctive
- distinctive feature
- distinctiveness
- Diversity
- division of powers
- divisionals
- DNA Patents
- domain
- domain names
- dominant feature
- dosage range
- Double Patenting
- doubtful cases
- due care
- E-Commerce
- Early dismissal
- economics
- errors
- essentiality of elements
- Ethics
- Europe
- Events
- Evidence
- examination quality
- examination statistics
- Examiner
- expert
- expert blinding
- expert evidence
- Experts
- expiry
- Expungement
- extraterritoriality
- federal circuit
- Federal Court
- Federal Court of Appeal
- fee
- fees
- file wrapper
- Filing
- filing date
- filing fee
- financial services
- foreign issue estoppel
- forum selection
- fraud
- Free World Trust
- frivolous
- funding
- future infringement
- generics
- geographical indications
- global
- Good Faith
- goods
- Government
- grace period
- grey marketing
- Hague
- hearsay
- hearsay evidence
- Honest Contractual Performance
- ICSID
- Illegality
- Improver
- imunity
- Indefiniteness
- Inducement
- Industrial Designs
- inherent distinctiveness
- injunction
- Injunctions
- Innovation
- insufficiency
- insufficient disclosure
- Intellectual Property
- intent
- Inter Partes Review
- interlocutory injunction
- Internet
- intra vires
- invalidated
- invalidation
- inventor removal
- inventorship
- IP Lawyer
- IP management
- ip regime
- IP Strategy
- IPIC
- IPO
- ISP
- IT patent
- ITC
- Jurisdiction
- Late fee
- Legal Retainer
- legal test
- legislative reform
- legitimate interest
- Licensing
- life science
- limitation periods
- Litigation
- litigation evidence
- litigation funding agreement
- madrid
- maintenance
- material facts
- materiality
- method
- Methods of Medical Treatment
- minister of health
- misleading
- monopoly
- motion
- Motion to dismiss
- Motion to strike
- NAFTA
- national phase entry
- new act
- new evidence
- no chance of success
- Non-Infringing Alternative
- notice of allegation
- notice to rectify
- novelty
- obivous error
- Obviousness
- Office
- official mark
- official marks
- on-sale
- on-sale bar
- Online
- ontario
- opposition
- outsourcing
- Overbreadth
- overlapping
- ownership
- Ownership & Inventorship
- PAB
- Passing Off
- patent abandonment
- Patent Act
- patent agent
- Patent Agents
- Patent and Trademark Appeal Board
- patent appeal board
- Patent Application
- Patent Drafting
- Patent Infringement
- Patent Litigation
- Patent Office
- patent office errors
- patent owner
- patent ownership
- patent practicioner
- patent prosecution
- patent protection
- patent requirement
- Patent Rules
- Patent Strategy
- patent term adjustment
- Patent Textbook
- Patent Trolls
- patentability
- Patentable Subject Matter
- Patents
- PCT
- Pharmaceutical Patent
- Pharmaceutical Pricing
- PLT
- PM(NOC)
- PM(NOC) Damages
- PMPRB
- POSITA
- price regulation
- pride
- prior art
- prior disclosure
- prior disclosure defence
- prior use
- priority
- priority claim
- priority claims
- priority date
- Privilege
- procedure
- Product Specificity
- profit
- prohibited marks
- Promise Doctrine
- proprietor
- Prosecution
- protective order
- prothonotaries
- Provisional Patent
- public sale
- Public Servant
- Punitive Damages
- Recognition
- Records
- registration
- reinstatement
- relevant date for construction
- Remedies
- representation
- request for correction
- requisition
- responding
- review
- risk
- Royalties
- s. 27
- s. 45
- s. 53
- sale
- Scheduling
- SCOTUS
- second person
- Secondary Infringement
- secondary meaning
- secret sale
- section 28
- Section 45
- section 50
- Section 52
- section 56
- section 7
- security
- selection patents
- Services
- settlement
- skilled person
- software
- Software Copyright
- Software Patent
- software patents
- Sound Prediction
- specification
- sponsorship
- SRED
- Standard of Review
- standing
- standing to appeal
- Start-up
- Startups
- statute of monopolies
- stay
- Strategy
- Sufficiency
- Summary Judgment
- summary trial
- superior court
- Supreme Court of Canada
- surname
- Technology
- test
- third party
- time frame
- top patent agent
- TPP
- Trade Secrets
- Trade-Mark
- trade-marks act
- Trademark
- Trademark Act
- trademark agent
- Trademark Infringement
- trademark opposition
- treaty
- UK
- united kingdom
- United States
- unpatentable
- untrue material allegation
- Use
- useful article
- USMCA
- USPTO
- Utility
- Validity
- variant
- Varying records
- Velocity
- vexatious
- who's who legal
August 1, 2017
August 1, 2017
2016 FC 1117 - Cascade brought a claim that Kinshofer had infringed its Canadian patent related to a safety locking device for quick couplers. After carrying out a claim construction, the FC did not find that the patent had been infringed.
July 18, 2017
July 18, 2017
2016 FC 606 - The FC dismissed TearLab’s application for an interlocutory injunction preventing I-MED from selling its i-Pen System, and ordered TearLab to pay security for costs.
July 11, 2017
July 11, 2017
2017 SCC 34 - Canada's Supreme Court dismissed Google Inc.’s appeal and upheld the worldwide interlocutory injunction against it.
June 13, 2017
June 13, 2017
2016 FC 382 - The FC concluded that Apotex’s allegations of non-infringement in respect of Shire's Canadian Patent were justified and accordingly denied Shire’s requested prohibition order.
May 30, 2017
May 30, 2017
2016 FCA 155 - The FCA overturned a FC decision in which it was held that the parties had settled the litigation, and had issued an order enforcing the terms of the settlement. The FCA found that a settlement had not in fact been reached, set aside the FC’s order and granted Apotex its appeal and costs.
May 23, 2017
May 23, 2017
581 U.S. ___ (2017) - SCOTUS reaffirmed one of its previous holdings to find that the proper venue for bringing a patent infringement suit against a domestic corporation is either where the defendant resides, or where the defendant has committed acts of infringement and has a regular place of business.
May 16, 2017
May 16, 2017
2017 FC 350 - The Federal Court outlined in this decision how the Dow Chemical Company should be compensated by Nova Chemicals Corporation for its infringement of Dow’s patent.
May 2, 2017
May 2, 2017
2017 FCA 9 - The FCA affirmed the FC decision that AstraZeneca’s patent was valid and infringed, accepted Apotex’s appeal with respects to limitation periods, and rejected AstraZeneca’s cross-appeal regarding punitive damages.
April 25, 2017
April 25, 2017
2016 FC 593 - The FC awarded Janssen Canada and Janssen US almost $19 million in total damages for Teva's infringement of a Japanese entity's patent, for which Janssen US had never even exercised its licence in Canada.
April 11, 2017
April 11, 2017
2016 FC 320 - The FC found that many of the claims in Uponor’s patent were invalid, rejected the untrue material allegation argument and found that several of the remaining claims were infringed by Heatlink and Pexcor.